Sarepta Therapeutics, Inc. (SRPT)
18.01
+0.03
(+0.17%)
USD |
NASDAQ |
Nov 12, 16:00
17.72
-0.29
(-1.61%)
After-Hours: 16:27
Sarepta Therapeutics Total Assets (Quarterly): 3.493B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.381B |
| Pfizer Inc. | 208.73B |
| Elanco Animal Health, Inc. | 13.55B |
| Eli Lilly & Co. | 114.94B |
| Hims & Hers Health, Inc. | 2.233B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.173B |
| Shareholders Equity (Quarterly) | 1.320B |
| Debt to Equity Ratio | 0.947 |
| Current Ratio | 2.950 |
| Net Debt Paydown Yield | 1.19% |